Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Correction to: Ret is essential to mediate GDNF's neuroprotective and neuroregenerative effect in a Parkinson disease mouse model.

Drinkut A, Tillack K, Meka DP, Schulz JB, Kügler S, Kramer ER.

Cell Death Dis. 2018 May 25;9(6):634. doi: 10.1038/s41419-018-0636-4.

2.

A Whole Blood Molecular Signature for Acute Myocardial Infarction.

Muse ED, Kramer ER, Wang H, Barrett P, Parviz F, Novotny MA, Lasken RS, Jatkoe TA, Oliveira G, Peng H, Lu J, Connelly MC, Schilling K, Rao C, Torkamani A, Topol EJ.

Sci Rep. 2017 Sep 25;7(1):12268. doi: 10.1038/s41598-017-12166-0.

3.

Erratum: Crowdsourced assessment of common genetic contribution to predicting anti-TNF treatment response in rheumatoid arthritis.

Sieberts SK, Zhu F, García-García J, Stahl E, Pratap A, Pandey G, Pappas D, Aguilar D, Anton B, Bonet J, Eksi R, Fornés O, Guney E, Li H, Marín MA, Panwar B, Planas-Iglesias J, Poglayen D, Cui J, Falcao AO, Suver C, Hoff B, Balagurusamy VSK, Dillenberger D, Neto EC, Norman T, Aittokallio T, Ammad-Ud-Din M, Azencott CA, Bellón V, Boeva V, Bunte K, Chheda H, Cheng L, Corander J, Dumontier M, Goldenberg A, Gopalacharyulu P, Hajiloo M, Hidru D, Jaiswal A, Kaski S, Khalfaoui B, Khan SA, Kramer ER, Marttinen P, Mezlini AM, Molparia B, Pirinen M, Saarela J, Samwald M, Stoven V, Tang H, Tang J, Torkamani A, Vert JP, Wang B, Wang T, Wennerberg K, Wineinger NE, Xiao G, Xie Y, Yeung R, Zhan X, Zhao C; Members of the Rheumatoid Arthritis Challenge Consortium, Greenberg J, Kremer J, Michaud K, Barton A, Coenen M, Mariette X, Miceli C, Shadick N, Weinblatt M, de Vries N, Tak PP, Gerlag D, Huizinga TWJ, Kurreeman F, Allaart CF, Bridges SL Jr, Criswell L, Moreland L, Klareskog L, Saevarsdottir S, Padyukov L, Gregersen PK, Friend S, Plenge R, Stolovitzky G, Oliva B, Guan Y, Mangravite LM.

Nat Commun. 2016 Oct 10;7:13205. doi: 10.1038/ncomms13205. No abstract available.

4.

Ret is essential to mediate GDNF's neuroprotective and neuroregenerative effect in a Parkinson disease mouse model.

Drinkut A, Tillack K, Meka DP, Schulz JB, Kügler S, Kramer ER.

Cell Death Dis. 2016 Sep 8;7(9):e2359. doi: 10.1038/cddis.2016.263. Erratum in: Cell Death Dis. 2018 May 25;9(6):634.

5.

Crowdsourced assessment of common genetic contribution to predicting anti-TNF treatment response in rheumatoid arthritis.

Sieberts SK, Zhu F, García-García J, Stahl E, Pratap A, Pandey G, Pappas D, Aguilar D, Anton B, Bonet J, Eksi R, Fornés O, Guney E, Li H, Marín MA, Panwar B, Planas-Iglesias J, Poglayen D, Cui J, Falcao AO, Suver C, Hoff B, Balagurusamy VSK, Dillenberger D, Neto EC, Norman T, Aittokallio T, Ammad-Ud-Din M, Azencott CA, Bellón V, Boeva V, Bunte K, Chheda H, Cheng L, Corander J, Dumontier M, Goldenberg A, Gopalacharyulu P, Hajiloo M, Hidru D, Jaiswal A, Kaski S, Khalfaoui B, Khan SA, Kramer ER, Marttinen P, Mezlini AM, Molparia B, Pirinen M, Saarela J, Samwald M, Stoven V, Tang H, Tang J, Torkamani A, Vert JP, Wang B, Wang T, Wennerberg K, Wineinger NE, Xiao G, Xie Y, Yeung R, Zhan X, Zhao C; Members of the Rheumatoid Arthritis Challenge Consortium, Greenberg J, Kremer J, Michaud K, Barton A, Coenen M, Mariette X, Miceli C, Shadick N, Weinblatt M, de Vries N, Tak PP, Gerlag D, Huizinga TWJ, Kurreeman F, Allaart CF, Louis Bridges S Jr, Criswell L, Moreland L, Klareskog L, Saevarsdottir S, Padyukov L, Gregersen PK, Friend S, Plenge R, Stolovitzky G, Oliva B, Guan Y, Mangravite LM.

Nat Commun. 2016 Aug 23;7:12460. doi: 10.1038/ncomms12460. Erratum in: Nat Commun. 2016 Oct 10;7:13205.

6.

Neuroprotective Effect of Coptis chinensis in MPP[Formula: see text] and MPTP-Induced Parkinson's Disease Models.

Friedemann T, Ying Y, Wang W, Kramer ER, Schumacher U, Fei J, Schröder S.

Am J Chin Med. 2016;44(5):907-25. doi: 10.1142/S0192415X16500506. Epub 2016 Jul 19.

PMID:
27430912
7.

[Temporary biokeratoprostheses in total destruction of the cornea].

Onishchenko AL, Kolbasko AV, Kramer ER.

Vestn Oftalmol. 2016 Mar-Apr;132(2):70-72. doi: 10.17116/oftalma2016132270-72. Russian.

PMID:
27213800
8.

The neuroprotective and regenerative potential of parkin and GDNF/Ret signaling in the midbrain dopaminergic system.

Kramer ER.

Neural Regen Res. 2015 Nov;10(11):1752-3. doi: 10.4103/1673-5374.165295. No abstract available.

9.

GDNF-Ret signaling in midbrain dopaminergic neurons and its implication for Parkinson disease.

Kramer ER, Liss B.

FEBS Lett. 2015 Dec 21;589(24 Pt A):3760-72. doi: 10.1016/j.febslet.2015.11.006. Epub 2015 Nov 7. Review.

10.

An Efficient and Versatile System for Visualization and Genetic Modification of Dopaminergic Neurons in Transgenic Mice.

Tillack K, Aboutalebi H, Kramer ER.

PLoS One. 2015 Aug 20;10(8):e0136203. doi: 10.1371/journal.pone.0136203. eCollection 2015.

11.

Crosstalk of parkin and Ret in dopaminergic neurons.

Kramer ER.

Oncotarget. 2015 Jun 30;6(18):15704-5. No abstract available.

12.

Parkin cooperates with GDNF/RET signaling to prevent dopaminergic neuron degeneration.

Meka DP, Müller-Rischart AK, Nidadavolu P, Mohammadi B, Motori E, Ponna SK, Aboutalebi H, Bassal M, Annamneedi A, Finckh B, Miesbauer M, Rotermund N, Lohr C, Tatzelt J, Winklhofer KF, Kramer ER.

J Clin Invest. 2015 May;125(5):1873-85. doi: 10.1172/JCI79300. Epub 2015 Mar 30.

13.

Self-reinforced composites of hydroxyapatite-coated PLLA fibers: fabrication and mechanical characterization.

Charles LF, Kramer ER, Shaw MT, Olson JR, Wei M.

J Mech Behav Biomed Mater. 2013 Jan;17:269-77. doi: 10.1016/j.jmbbm.2012.09.007. Epub 2012 Sep 29.

PMID:
23127637
14.

Sonic hedgehog maintains cellular and neurochemical homeostasis in the adult nigrostriatal circuit.

Gonzalez-Reyes LE, Verbitsky M, Blesa J, Jackson-Lewis V, Paredes D, Tillack K, Phani S, Kramer ER, Przedborski S, Kottmann AH.

Neuron. 2012 Jul 26;75(2):306-19. doi: 10.1016/j.neuron.2012.05.018.

15.

Image enhancement in ultramicroscopy by improved laser light sheets.

Saghafi S, Becker K, Jährling N, Richter M, Kramer ER, Dodt HU.

J Biophotonics. 2010 Oct;3(10-11):686-95. doi: 10.1002/jbio.201000047.

PMID:
20575105
16.

Pro-survival role for Parkinson's associated gene DJ-1 revealed in trophically impaired dopaminergic neurons.

Aron L, Klein P, Pham TT, Kramer ER, Wurst W, Klein R.

PLoS Biol. 2010 Apr 6;8(4):e1000349. doi: 10.1371/journal.pbio.1000349.

17.

Ultramicroscopy: 3D reconstruction of large microscopical specimens.

Becker K, Jährling N, Kramer ER, Schnorrer F, Dodt HU.

J Biophotonics. 2008 Mar;1(1):36-42. doi: 10.1002/jbio.200710011.

PMID:
19343633
18.

The Rab5 guanylate exchange factor Rin1 regulates endocytosis of the EphA4 receptor in mature excitatory neurons.

Deininger K, Eder M, Kramer ER, Zieglgänsberger W, Dodt HU, Dornmair K, Colicelli J, Klein R.

Proc Natl Acad Sci U S A. 2008 Aug 26;105(34):12539-44. doi: 10.1073/pnas.0801174105. Epub 2008 Aug 22.

19.

Polymorphisms in the receptor for GDNF (RET) are not associated with Parkinson's disease in Southern Germany.

Lücking CB, Lichtner P, Kramer ER, Gieger C, Illig T, Dichgans M, Berg D, Gasser T.

Neurobiol Aging. 2010 Jan;31(1):167-8. doi: 10.1016/j.neurobiolaging.2008.03.006. Epub 2008 Apr 23.

PMID:
18436345
20.

The protein dendrite arborization and synapse maturation 1 (Dasm-1) is dispensable for dendrite arborization.

Mishra A, Knerr B, Paixão S, Kramer ER, Klein R.

Mol Cell Biol. 2008 Apr;28(8):2782-91. doi: 10.1128/MCB.02102-07. Epub 2008 Feb 11.

21.

RET signaling does not modulate MPTP toxicity but is required for regeneration of dopaminergic axon terminals.

Kowsky S, Pöppelmeyer C, Kramer ER, Falkenburger BH, Kruse A, Klein R, Schulz JB.

Proc Natl Acad Sci U S A. 2007 Dec 11;104(50):20049-54. Epub 2007 Dec 4.

22.

Absence of Ret signaling in mice causes progressive and late degeneration of the nigrostriatal system.

Kramer ER, Aron L, Ramakers GM, Seitz S, Zhuang X, Beyer K, Smidt MP, Klein R.

PLoS Biol. 2007 Mar;5(3):e39.

23.

Cooperation between GDNF/Ret and ephrinA/EphA4 signals for motor-axon pathway selection in the limb.

Kramer ER, Knott L, Su F, Dessaud E, Krull CE, Helmbacher F, Klein R.

Neuron. 2006 Apr 6;50(1):35-47.

24.

Emi1 is a mitotic regulator that interacts with Cdc20 and inhibits the anaphase promoting complex.

Reimann JD, Freed E, Hsu JY, Kramer ER, Peters JM, Jackson PK.

Cell. 2001 Jun 1;105(5):645-55.

25.
26.

Nonperiodic activity of the human anaphase-promoting complex-Cdh1 ubiquitin ligase results in continuous DNA synthesis uncoupled from mitosis.

Sorensen CS, Lukas C, Kramer ER, Peters JM, Bartek J, Lukas J.

Mol Cell Biol. 2000 Oct;20(20):7613-23.

27.

Cell cycle- and cell growth-regulated proteolysis of mammalian CDC6 is dependent on APC-CDH1.

Petersen BO, Wagener C, Marinoni F, Kramer ER, Melixetian M, Lazzerini Denchi E, Gieffers C, Matteucci C, Peters JM, Helin K.

Genes Dev. 2000 Sep 15;14(18):2330-43.

28.

Mitotic regulation of the APC activator proteins CDC20 and CDH1.

Kramer ER, Scheuringer N, Podtelejnikov AV, Mann M, Peters JM.

Mol Biol Cell. 2000 May;11(5):1555-69.

29.

Expression of the CDH1-associated form of the anaphase-promoting complex in postmitotic neurons.

Gieffers C, Peters BH, Kramer ER, Dotti CG, Peters JM.

Proc Natl Acad Sci U S A. 1999 Sep 28;96(20):11317-22.

30.

Activation of the human anaphase-promoting complex by proteins of the CDC20/Fizzy family.

Kramer ER, Gieffers C, Hölzl G, Hengstschläger M, Peters JM.

Curr Biol. 1998 Nov 5;8(22):1207-10.

31.

[The treatment of vascular optic neuropathies].

Eremenko AI, Chavdar NI, Kungurova SM, Faustova AM, Moiseeva L, Eremenko IG, Kramer ER.

Oftalmol Zh. 1990;(1):25-8. Russian.

PMID:
2280918
32.

Modifications of the pharmacology of reserpine and serotonin by iproniazid.

CHESSIN M, KRAMER ER, SCOTT CC.

J Pharmacol Exp Ther. 1957 Apr;119(4):453-60. No abstract available.

PMID:
13429452

Supplemental Content

Loading ...
Support Center